$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
厄达替尼用法用量是怎样的?厄达替尼的副作用是什么?
2025-10-19 11:44:20
Check Details
尿路上皮癌新药-Padcev
2025-10-19 11:44:20
Check Details
Padcev现在在南昌可以购买到吗?
2025-10-19 11:44:20
Check Details
欧盟专家组确认Padcev用于局部晚期或转移性尿路上皮癌的建议
2025-10-19 11:44:20
Check Details
Enfortumab vedotin-ejfv治疗局部晚期或转移性尿路上皮癌
2025-10-19 11:44:20
Check Details
Enfortumab vedotin-ejfv需要静脉输注吗?要注意什么
2025-10-19 11:44:20
Check Details
尿路上皮癌首款ADC药物——Padcev在欧盟即将获批
2025-10-19 11:44:20
Check Details
Enfortumab vedotin-ejfv是什么药?可以用医保购买吗?
2025-10-19 11:44:20
Check Details
吃厄达替尼能活多久,疗效好吗?
2025-10-19 11:44:20
Check Details
恩诺单抗2022最新价格,多少钱一支?
2025-10-19 11:44:20
Check Details
恩诺单抗治疗尿路上皮癌:Ⅱ期多中心研究中客观缓解率为44%!
2025-10-19 11:44:20
Check Details
厄达替尼常见的不良反应你知道哪些?
2025-10-19 11:44:20
Check Details
1
2
...
43
44
45
46
47
48
49
...
4151
4152
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
A Revolutionary Targeted Therapy for Hematological Malignancies
2
A New Option for Advanced Renal Cell Carcinoma Treatment
3
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
4
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
5
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide
6
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications
7
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment
8
Comprehensive Analysis of the Third-Generation EGFR-TKI
9
ATOMIC Study: Atezolizumab Plus Chemo Improves DFS in dMMR Stage III Colon Cancer
10
Oncology Immunotherapy vs Anti-Inflammatory Biologic: Dostarlimab vs Secukinumab - A Mechanism-Centered Comparison
11
Third-Generation TKI Redefining Treatment for ALK+ & ROS1+ NSCLC
12
Brigatinib Medication Case Study: Three-Year Treatment Record and Experience Sharing of ALK-Positive Lung Cancer Patient